Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (701-710 of 706) with videos related to

Pageof 71
Sort By:
You have reached the last page of results.This site can display upto 706 results.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
European Journal of Preventive Cardiology|May 14, 2026
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registryJoana Rita Chora, Irene Karungi, Amany Elshorbagy, et al.
Atherosclerosis|October 2, 2018
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), Antonio J Vallejo-Vaz, Martina De Marco, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
JAMA Cardiology|January 3, 2020
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action, Katherine A Wilemon, Jasmine Patel, et al.
Pageof 71

Showing results (701-710 of 706) with videos related to

Sort By:
Pageof 71
You have reached the last page of results.This site can display upto 706 results.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
European Journal of Preventive Cardiology|May 14, 2026
Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registryJoana Rita Chora, Irene Karungi, Amany Elshorbagy, et al.
Atherosclerosis|October 2, 2018
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), Antonio J Vallejo-Vaz, Martina De Marco, et al.
European Heart Journal|January 13, 2025
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registryAmany Elshorbagy, Antonio J Vallejo-Vaz, Fotios Barkas, et al.
JAMA Cardiology|January 3, 2020
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action, Katherine A Wilemon, Jasmine Patel, et al.
Pageof 71